Diosgenin prevents periodontitis by inhibiting inflammation and promoting osteogenic differentiation
Oral Diseases · 2024
DOI: 10.1111/odi.14708 ↗Kurz gefasst
Fachartikel in der Zeitschrift Oral Diseases, 2024. Verfasst von Shaohua Cong und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Stomatology, Jiading District Central Hospital Affiliated Shanghai University of Medicine and Health Sciences, Shanghai, China. Hauptthemen laut MEDLINE: Diosgenin, Periodontitis, Osteogenesis, Cell Differentiation. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Clinical Research Center of Shanghai University of Medicine & Health Sciences, Scientific research project of Shanghai Jiading District Health Committee, The Nature Science Foundation of Jiading District, Shanghai.
Abstract (Originalsprache)
Diosgenin, an essential dietary steroidal sapogenin, possess multiple pharmacological activities. This study aimed to assess the effects of diosgenin on periodontitis and elucidate the mechanisms. Lipopolysaccharide (LPS)‐stimulated human periodontal ligament stem cells (hPDLCs) and a Porphyromonas gingivalis (P.g) plus ligation‐induced animal model were used for in vitro and in vivo studies, respectively. Inflammatory responses, nuclear factor κ‐B (NF‐κB) signaling and osteogenesis‐related markers were measured both in LPS‐stimulated hPDLSCs and in gingival tissue of periodontitis rats. Treatment with diosgenin significantly inhibited the production of tumor necrosis factor α (TNF‐α), interleukin (IL)‐1β, and interleukin (IL)‐6 and the activation of NF‐κB pathway in LPS‐stimulated hPDLSCs. Further, treatment with diosgenin enhanced the expression of osteoblast‐related genes and increased the osteogenic differentiation capacity. Further, activation NF‐κB pathway largely abolished the protective effects of diosgenin. Consistent with the in vitro studies, in vivo studies showed that administering diosgenin to periodontitis rats significantly lowered the levels of the TNF‐α, IL‐1β, and IL‐6 and the inflammatory transcription factor NF‐κB in gingival tissue. In addition, osteoblast‐related genes were promoted. Diosgenin attenuates periodontitis by adjusting NF‐κB signaling to inhibit inflammatory effects and promoting osteogenesis, suggesting diosgenin might be developed as a therapeutic strategy for treating periodontitis in the future.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Stomatology, Jiading District Central Hospital Affiliated Shanghai University of Medicine and Health Sciences, Shanghai, China.
- Plastic and Reconstructive Surgery, Hubei No. 3 People's Hospital of Jianghan University, Wuhan, China.
- Department of Nephrology, School of Medicine, Renji Hospital, Shanghai Jiao Tong University, Shanghai, China.
- Clinical Research Center, Jiading District Central Hospital Affiliated Shanghai University of Medicine and Health Sciences, Shanghai, China.
ORCID-Profile: Dongyu Liang
Förderung
- Clinical Research Center of Shanghai University of Medicine & Health Sciences
- Scientific research project of Shanghai Jiading District Health Committee
- The Nature Science Foundation of Jiading District, Shanghai
Zitieren
APA
Cong, S., Peng, Q., Cao, L., Yi, Q., Liu, Y., Li, L., Tong, Q., & Liang, D. (2024). Diosgenin prevents periodontitis by inhibiting inflammation and promoting osteogenic differentiation. Oral Diseases. https://doi.org/10.1111/odi.14708
Vancouver
Cong S, Peng Q, Cao L, Yi Q, Liu Y, Li L, et al. Diosgenin prevents periodontitis by inhibiting inflammation and promoting osteogenic differentiation. Oral Diseases. 2024. doi:10.1111/odi.14708
BibTeX
@article{Cong2024,
author = {Cong, Shaohua and Peng, Qian and Cao, Liou and Yi, Qingqing and Liu, Yi and Li, Linhui and Tong, Qingchun and Liang, Dongyu},
title = {Diosgenin prevents periodontitis by inhibiting inflammation and promoting osteogenic differentiation},
journal = {Oral Diseases},
year = {2024},
doi = {10.1111/odi.14708}
}
EUVIMED